LakeShore Biopharma Co (LakeShore Biopharma Co) Long-Term Capital Lease Obligation : $0.61 Mil (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Long-Term Capital Lease Obligation?

LakeShore Biopharma Co's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.61 Mil.

LakeShore Biopharma Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2022 ($1.48 Mil) to Mar. 2023 ($0.92 Mil) and declined from Mar. 2023 ($0.92 Mil) to Sep. 2023 ($0.61 Mil).

LakeShore Biopharma Co's annual Long-Term Capital Lease Obligation declined from Mar. 2021 ($2.08 Mil) to Mar. 2022 ($1.67 Mil) and declined from Mar. 2022 ($1.67 Mil) to Mar. 2023 ($0.92 Mil).

LakeShore Biopharma Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for LakeShore Biopharma Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Long-Term Capital Lease Obligation Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Long-Term Capital Lease Obligation

2.08

1.67

0.92

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial			-	1.67	1.48	0.92	0.61

LakeShore Biopharma Co (NAS:LSB) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

LakeShore Biopharma Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.